8 completed. 4 Phase 1, 2 Phase 2, 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 4 |
| Phase 2 | 2 | Completed 2 |
| Phase 3 | 1 | Completed 1 |
| Phase 4 | 1 | Completed 1 |
Follow Anthrax Vaccines: new trials by email Literature Review of Anthrax Vaccines trials Research Report on Anthrax Vaccines
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 1 Ascending Dose Study to Assess the Safety and Immunogenicity of Adenovirus Anthrax Vector Candidate Vaccines AVA, Ad4-PA-1, Ad4-PA-GPI-1 - Anthrax Infection | Phase 1 | Completed | Emergent BioSolutions | 120 | 2013-11-01 | 2024-03-18 |
| A Phase 2 Safety and Immunogenicity Study for an Anthrax Vaccine Using 3 Schedules and Two Dose Levels AV7909, BioThrax - Anthrax | Phase 2 | Completed | Emergent BioSolutions | 168 | 2013-01-01 | 2024-03-18 |
| Ciprofloxacin BioThrax Co-Administration Study BioThrax, Ciprofloxacin - Anthrax | Phase 2 | Completed | Emergent BioSolutions | 154 | 2012-12-01 | 2025-06-15 |
| Immunogenicity and Safety Study of a Three-Dose BioThrax® Regimen for Post-Exposure Prophylaxis in Healthy Adults BioThrax - Anthrax | Phase 3 | Completed | Emergent BioSolutions | 200 | 2011-11-01 | 2024-04-09 |
| Safety, Tolerability and Immunogenicity Study of AV7909 Anthrax Vaccine in Healthy Adults BioThrax, AV7909 Formulation 1, AV7909 Formulation 2 - Bacillus Anthracis (Anthrax) Infection | Phase 1 | Completed | Emergent BioSolutions | 105 | 2010-12-01 | 2024-03-18 |
| Anthrax Vaccine Clinical Trials Anthrax Vaccine, Blood Chemistry, Hematology - Anthrax | Phase 1 | Completed | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 93 | 2004-09-08 | 2017-07-02 |
| Anthrax-rPA: Safety, Tolerability, Immunogenicity Recombinant Protective Antigen, Anthrax Vaccine Adsorbed - Anthrax | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 80 | 2003-07-01 | 2010-08-27 |
| Anthrax Vaccine Clinical Trial to Assess Dose Reduction and Route Change Anthrax Vaccine Adsorbed, Saline injection - Healthy | Phase 4 | Completed | Centers for Disease Control and Prevention | 1564 | 2002-05-01 | 2024-05-29 |
Anthrax (8) · Infections (1)
Emergent BioSolutions (5) · Centers for Disease Control and Prevention (1) · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1)
United States (8)
Robert Hopkins, MD, MPH, TM (2) · Clay W. Mash, Ph.D. (1) · Edward Bernton, MD (1) · Gurdyal Kalsi, MD, MTOPRA (1) · Jakub Simon, MD (1) · Jennifer Wright, DVM (1) · Marc Gurwith, MD (1) · Mo Elsafy, MD, MSc (1)
PMID 21368772, PMID 23701746, PMID 23741398, PMID 24373307, PMID 26865594, PMID 38352727